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Background: With over two million people suffering from opioid abuse disorders, the Centers
for Medicare and Medicaid Services has identified opioid abuse as a key priority. Florida is one
of eight states labeled as a high-burden opioid abuse and is an “epicenter” for opioid use and
misuse. Purpose: The purpose of this study was to discover potential predictors of opioid abuse
in Florida by exploring specific healthcare delivery, geographic, and patient demographic
factors. Methods: A retrospective longitudinal study design was used to examine four years
(2014-2017) of Florida inpatient administrative discharge data across 173 hospitals of opioid
abuse rate. Main measures included, opioid abuse counts (n=12,804) defined using both ICD-9CM and ICD-10-CM systems. Negative binomial regression was used to estimate the
association between hospital factors, county factor, and opioid abuse hospital rates. Results:
We found a statistically significant association between hospital opioid abuse count and
hospital size, location, teaching status, patients’ average age, gender, and race. The estimated
probability of opioid abuse for a patient if treated in a large hospital is 0.23 (about 23%),
significantly higher than small (8%) and medium (17%) size hospitals. The estimated
probability of opioid abuse for a patient if treated in a rural hospital is 0.12 (about 12%), while
in an urban hospital is higher at 0.17 (about 17%). The risk ratio is 0.71, which means the risk
decreased by two-thirds when treated in rural hospitals. We also found that hospitals with a
younger patient population, a higher percent of males and a higher proportion of Caucasian
patients, are at a higher risk for an increase in opioid abuse counts. Discussion: These findings
provide policymakers with crucial insight into Florida’s opioid crisis and the identification of
predictive factors that contribute to opioid abuse.

________________________________________________________________________________________
Background | The Center for Medicare and Medicaid
Services (CMS) identified opioid abuse as a critical
priority for 2019 and is expected to continue as a
priority over the next five years.1 Opioid abuse is
characterized as the “intentional, nontherapeutic use of
a drug or substance for the purpose of achieving a
psychological or physiological effect.” 2 Strong
evidence shows that opioid abuse is causing a
significant economic burden by directly impacting
costs of care, utilization, and societal financial
burden.3 Studies have attempted to identify risk factors
that could predict opioid overdose, often for patients
with specified morbidity or focused on specific highrisk populations.4,5 A medical claims data study of
over 42,000 Colorado patients taking chronic opioid
therapy, found that mental health diagnoses, substance
use disorders, long-acting and extended-release opioid
formulations, and tobacco use were significant opioid
overdose predictors.4
However, there is very little research on hospital
structural characteristics and their potential influence
on opioid abuse. Most studies explore the impact of

hospital structure on opioid related adverse events, for
example, one study was identified that researched
hospitals in 32 states participating in the Healthcare
Cost and Utilization Project (HCUP). This study found
that preventable opioid related adverse events were
higher in urban teaching hospitals as well as private,
However, since the
not-for-profit hospitals.6
community and its health system are connected,7 there
may be an influence of hospital structural
characteristics and opioid abuse. This influence should
be further examined due to the absence of outpatient
factors in consideration.
Florida is one of eight states that is labeled a highburden opioid abuse. Florida suffers from one of the
highest concentrations of fentanyl-related overdoses
and is considered an “epicenter” for opioid use.8,9 In
Florida, synthetic opioids are responsible for the sharp
increase in abuse, characterized by high overdose
deaths. In 2018, the overdose death rate in Florida was
15.8 per 100,000. This was higher than the national
average of 14.6 per 100,000.10 In 2017, Fentanyl and
Fentanyl analogs contributed to around 28,400 deaths,
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the sharpest increase in overdose deaths.10 While
Florida’s opioid-related emergency department visit
rates have drastically increased by 32.3% from 2009
to 2014,11 prescription rates have decreased by as
much as 80%.12 This decrease is possibly a result of
Florida’s prescription drug monitoring programs and
“pill mill” laws.9 However, despite the decrease,
inpatient stays due to opioid utilization in Florida are
far higher than the national average.13 Thus, this study
explored the potential predictive relationship between
patient
characteristics,
hospital
structural
characteristics and county characteristics and their
predictive impact on opioid abuse.

FID data contained over 13 million discharges for all
hospitals in Florida and recorded information
regarding the patients, diagnoses, procedures, costs
and attending physicians. Specifically, the data
recorded 30 diagnosis codes and procedure codes,
making it a comprehensive dataset for diagnosis
selection. The AHA annual survey collects
information about all U.S. hospitals regarding
organizational structure, financial well-being,
workforce, and services. The CPS collects information
on household adults 18 years of age or older and
provides 1- and 5-year estimates of population
characteristics.

Methods | Data Sources The 2014-2017 Florida
Inpatient Discharge (FID) data was obtained from the
Agency for Health Care Administration’s Center for
Health Information and Transparency and linked to the
2017 American Hospital Association (AHA) annual
survey using Medicare Provider Numbers. Also, we
used the 2014-2017 US Census Bureau Current
Population Survey (CPS) and linked it using county
Federal Information Processing Standards (FIPS). The

Variables and Measures Outcome variable. Our
primary outcome variable was a hospital’s total
number of opioid abuse related stays during our study
period (2014 to 2017). Opioid abuse stays were
identified using principle and secondary ICD-9-CM
and ICD-10-CM codes presented in Table 1. The
codes were extracted from prior research and the
Healthcare Cost and Utilization Project (HCUP).14,15

Table 1: ICD-9-CM and ICD-10-CM Opioid-Abuse Diagnosis Codes
ICD-9-CM
ICD-10-CM
Description
Code
Code
305.50
Opioid abuse, unspecified
305.51
Opioid abuse, continuous
305.52
Opioid abuse, episodic
F11.10
Opioid abuse, uncomplicated
F11.120
Opioid abuse with intoxication, uncomplicated
F11.121
Opioid abuse with intoxication delirium
F11.122
Opioid abuse with intoxication with perceptual disturbance
F11.129
Opioid abuse with intoxication, unspecified
F11.14
Opioid abuse with opioid-induced mood disorder
F11.150
Opioid abuse with opioid-induced psychotic disorder with delusions
F11.151
Opioid abuse with opioid-induced psychotic disorder with hallucinations
F11.159
Opioid abuse with opioid-induced psychotic disorder, unspecified
F11.181
Opioid abuse with opioid-induced sexual dysfunction
F11.182
Opioid abuse with opioid-induced sleep disorder
F11.188
Opioid abuse with other opioid-induced disorder
F11.19
Opioid abuse with unspecified opioid-induced disorder
Demographics of Patient Population. We identified
key factors that have previously been identified as
critical to determining opioid use, which included
patient age, gender, patient priority level, and
ethnicity.16-18 Patient age was reported as a hospital’s
median patient age for the study year. Gender was
reported as the percent of female patients at the
hospital. Insurance status was reported as the percent
of patients with commercial health insurance. Patient
priority level was reported as hospitals’ percent of
non-elective admissions. Non-elective admissions
included emergency, urgent, and trauma admissions.
Lastly, we included patient ethnicity, and it was

reported as hospitals’ percent of patients who identify
as African Americans or Blacks and hospitals’ percent
of patients who identify as Latino/Hispanic.
Hospital Characteristics. We identified vital hospital
factors that have previously been found to impact
patient utilization and community health. Hospital
ownership was reported as a categorical variable (notfor-profit, for-profit, and government-owned). An
indication of the health of the community and services
available are indicative of hospital ownership status.19
Hospital location was reported as a categorical
variable (rural and urban) and indicates hospital
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https://digitalcommons.unf.edu/fphr/vol17/iss1/5

36
2

Haley et al.: Structural and Social Determinants of Opioid Abuse Among Floridaresources, and state or federal funding support as
urban hospitals have been found to be better funded
and more efficient than rural hospitals.20 Hospital size
was reported as a categorical variable of the number of
staffed hospital beds (small <100, medium<400, and
large 400+) and is an indication of hospital quality and
market power.21 Teaching status was reported as a
categorical variable (major, minor, non-teaching) and
is an indication of hospital safety and quality.22
Finally, we estimated an average hospitals’ market
competition using the Herfindahl-Hirschman Index
(HHI). A hospital HHI is a ratio of the total inpatient
days and county’s total inpatient days (all hospitals in
the county). A HHI of 0 is an indication of a
competitive market, while an HHI of 1 is an indication
of a monopolistic market.23,24
County Characteristics. At the county level, we
examined community diversity and poverty for the
study period. These two variables provide insight into
the county’s health disparity and health.25 We used an
inequality index score that examines the amount of
diversity and population evenness within a county, 26
which we estimated by calculating the sum of the log
proportions of each of the six racial/ethnic groups
present in the US. These groups are African
Americans, American
Indians
or
Alaskan
Natives, Asians, Native Hawaiians or other Pacific
Islanders, Latino/Hispanics, and non-Latino/Hispanic
Whites. The closer the score to 1.79, the more diverse
(i.e., even) the population.27 County poverty was
reported as the percent of the population below the
federal poverty. These characteristics are necessary to
evaluate the potential relationship between
demographic factors and opioid misuse and abuse.
Approach We chose to analyze the counts for opioid
abuse counts at the hospital level due to the extremely
low incidence at the individual patient level (0.56%
overall). A retrospective longitudinal study design was
used to examine four years (2014-2017) of Florida
inpatient medical discharge data across 173 unique
hospitals (a total of 12,804 opioid abuse incidents).
The opioid abuse counts were analyzed using a
generalized linear mixed model with a negative
binomial distribution and a log-link function. The

model included the hospital characteristics (ownership
type, location, size, teaching affiliation), patient
demographics at hospital level (average age, percent
of female patients, percent of African American
patients, percent of Latino/Hispanic patients, and
percent of cases admitted through emergency/urgent
care/trauma) and county-level characteristics
(diversity index, HHI index and poverty percent) as
fixed covariates. A random intercept was added for
each provider to account for the random variation. The
year was also included as another fixed covariate to
examine the trend over time. The model also
accounted for the difference in hospital sizes by using
an offset variable (log of the total number of patients
for each year); therefore, a fair comparison on the
negative binomial rate (the probability of having an
opioid abuse case for an individual patient) can be
made. Generalized Chi-Square over degrees of
freedom and residual plots were used to assess the
goodness of fit of the model. The Kenward, Roger 28
method was used for the calculation of the
denominator degrees of freedom.29 All analyses were
performed using SAS software, version 9.4.30 In
accordance with the policy of the University, the
Institutional Review Board (IRB) categorized the
research as exempt since the study analyzed secondary
data that is publicly available.
Results | Figure 1 shows the distribution of opioid
abuse counts in Florida hospitals for each year from
2014 to 2017. The general patterns are similar from
year to year, with a gradual increase in the right tails,
which indicates the number of hospitals with a
relatively high number of opioid abuse counts has
increased.
Table 2 displays the descriptive statistics of the opioid
abuse counts at the hospital level from 2014 to 2017 in
Florida. The mean and median number of opioid abuse
reports steadily increased from 2014 to 2017. In
addition, more hospitals reported a higher number of
opioid abuse events during 2014 to 2017. For example,
2 hospitals reported more than 100 opioid abuse events
in 2014 and 2015, compared with 7 hospitals in 2016
and 2017. The standard deviations from table 2 also
confirm the spread of distribution from 2014 to 2017.
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Figure 1: Florida Hospital Opioid Abuse Counts Distribution by Year

Table 2: Summary of Florida Hospital Opioid Abuse Counts by Year
2014
2015
Hospital, N
170
168
Opioid Abuse
Mean
12.5
16.2
STD
17.4
23.9
Median
6.0
8.0
Min
0
0
Max
117
203
Note: N: number of hospitals with records; STD: standard deviation
Table 3 displays the parameter estimate results for all
key variables in the model, except for the ownership
type, which was not significant; all the other variables
of hospital characteristics were statistically
significant. All variables of patient demographics were
statistically significant. The diversity index was the
only variable that was statistically significant at the
county level. Compared with 2014, the opioid abuse
rate was significantly increased in 2016 and 2017
(2015 was not statistically significantly different from
in 2014). Furthermore, we may estimate the
relationship between each of the variables with the risk
(probability) of a patient encountering opioid abuse at
a hospital. For example, hospitals with a younger
patient mix, a higher percent of male patients, and a

2016
170

2017
168

22.2
31.4
12.0
0
230

24.9
33.6
13.5
0
220

higher proportion of Caucasian patients more likely to
report a higher incidence of opioid abuse. Patients
treated in hospitals located in a county with a higher
diversity index tend to have a higher risk of opioid
abuse. The estimated coefficients also show the
magnitude of impact for each variable. For example,
the variable ‘Mean Age’ has a coefficient of -0.053,
which means that for each one-year increase on
average age in the patient population, the expected log
of the negative binomial rate decreases by 0.05. On the
other hand, the variable ‘Diversity Index’ has a
coefficient of 1.01, which means that for each one-unit
increase on the diversity index score, the expected log
of the negative binomial rate increases by 1.01.
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Table 3: Negative Binomial Regression Parameter Estimates
Variable
Year (referent: 2014)
2015
2016
2017
Hospital Characteristics
Ownership Status (Referent: Not-for-profit)
For-profit
Government
Location (Referent: Urban)
Rural
Size (Referent: Small)
Large
Medium
Teaching Status (Referent: Non-Teaching)
Major
Minor
Patient Characteristics
Mean Age
Percent Female
Percent Emergency, Urgent and Trauma Admissions
Percent African American
Percent Latino/Hispanic
County Characteristics
Diversity Index
Herfindahl-Hirschman Index
Percent Poverty
Note: * significant at 0.05; ** significant at 0.01
Table 4 displays the estimate of the opioid abuse rate
(risk/probability of a patient being opioid abused) for
all the categorical variables in the model. The risk
ratios were calculated from the estimates. The risk
ratio in this context is the risk of opioid abuse when a
patient is treated in each condition versus the reference
level. Using hospital location, for example, the
estimated probability of opioid abuse for a patient if
treated in a rural hospital is 0.12 (about 12%), while in
an urban hospital is 0.17 (about 17%). The risk ratio is
0.71, which means the risk of opioid abuse is
decreased by 30% when a patient is treated in rural
hospitals. No significant difference is discovered in
the hospital ownership type, with the risk at 14%. For

Coefficient
0.11*
0.42**
0.54**
-0.05
-0.004
-0.37
1.09**
0.77**
0.15
0.24**
-0.05**
-0.05**
0.02**
-0.01*
-0.02**
1.01**
0.23
0.01
hospital size, the risks of a patient to be opioid abused
is 22%, 17%, and 8% when treated in large, medium,
and small hospitals, respectively. The risk ratios are
2.96 (large vs. small) and 2.16 (medium vs. small),
which indicates the risk is significantly higher at large
or medium hospitals compared with small hospitals.
There is no significant difference in the risk between
major and minor teaching hospitals. However, the risk
at both major and minor teaching hospitals is higher
than the non-teaching hospitals. Lastly, the increasing
trend of opioid abuse rates is observed starting from
2016. The increase in the risk of opioid abuse over
time may need more attention from the policymakers
in Florida.
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Table 4: Negative Binomial Regression Opioid Abuse Rate Estimates
Main Effect
LS Mean
Lower CL
Location
Rural
0.12
0.07
Urban
0.17
0.14
Ownership status
For-profit
0.14
0.1
Government
0.14
0.10
Not-for-profit
0.14
0.11
Size
Large
0.23
0.16
Medium
0.17
0.12
Small
0.08
0.05
Teaching status
Major
0.15
0.10
Minor
0.16
0.12
Non-Teaching
0.12
0.10
Year
2015
0.12
0.09
2016
0.17
0.13
2017
0.19
0.14
2014
0.11
0.08
Note: LS: least squares; CL: confident level
Discussion | This study examined potential predictors
of opioid abuse in Florida through specific healthcare
delivery, geographic, and patient demographic factors.
The results from this study suggest that hospitals in
Florida are continuously reporting higher counts of
opioid abuse over the years. Our binomial regression
analysis indicated a statistically significant increase in
opioid abuse in Florida. A probable explanation for
these results is a decrease in the uninsured population
and an increase in the awareness of opioid misuse
leading to more accurate reporting.
For example, the passing of the 2010 Patient
Protection and Affordable Care Act (ACA) provided a
reduction of financial barriers for the treatment of
opioid use disorders.31 Changes under the ACA
increased access to hospitals by removing the
administrative barriers that impeded the timely
payment for clinician reimbursement allowing
hospitals to be more prone to addressing this issue 32.
This change allowed for an increase in treatment
access and utilization, which may explain the
increased reporting. In addition, in 2015 the US began
using the ICD-10-CM, which increased codes from
14,000 to 68,000 codes, which may have contributed
to more accurate documentation of patients with
opioid abuse disorders and a 14.1% increase of
inpatient stays with opioid-related diagnoses.14
Furthermore, our study found a significant relationship
between hospital size and volume increase of opioid

Upper CL

Risk Ratio

0.19
0.20

0.71

0.18
0.21
0.19

0.95
0.95

0.31
0.22
0.11

2.96
2.16

0.21
0.21
0.16

1.16
1.27

0.16
0.22
0.25
0.14

1.03
1.40
1.47

abuse. Large and medium-sized hospitals were found
to experience higher counts of patients with opioid
abuse disorders compared to small-sized hospitals
even when we adjust for other factors. This may be
attributed to any number of factors, including the
possibility of larger hospitals to have more resources
compared to their small and medium counterparts. Our
results showed that out of a total of 183 hospitals, 170
reported they had encountered patients with opioid
abuse disorder with 3% from the total sample that did
not report. Perhaps larger hospitals have the resources
to better identify patients with opioid abuse disorder.
Our findings also indicated that the majority of Florida
hospitals with a higher risk for opioid abuse are
located in urban areas. A possible explanation for this
finding would be that urban populations are more
susceptible to abuse due to better access to
prescription opioids. While one study 33 showed that
residents living in rural counties are more likely to take
opioids for pain relief compared to those living in
urban areas, another study34 showed that individuals in
urban areas are more likely to engage in misuse
because of their higher exposure to other substances
and access to care. A study by Sears, Edmonds, &
Fulton-Kehoe35 found a higher prevalence of
prescribing physicians and pharmacists in urban areas.
Trends in studies show that abundant supplies of
opioids are positively correlated to abuse in urban
areas with individuals in urban counties having
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pharmacies.33,36,37
Another study from Cerdá et al.38 supports this
sentiment by finding a correlation between changes in
pharmacy density and opioid abuse discharge rates in
urban areas, particularly prescription-opioid poisoning
rates. As prescription opioids are more readily
available in urban settings, the risk of abuse in such
areas increases consequently. Individuals in rural areas
would have less access to treatment programs and
would likely have to travel to urban areas in order to
get access to treatment.39 Another study found that
treatment services are more readily available to urban
residents than their rural counterparts.40 In addition,
one study found a correlation between concentrated
homelessness in urban settings and higher risks of
opioid abuse with homeless individuals having a
disproportionately higher risk of opioid abuse
disorders compared to individuals of lower-income
households.41
Regarding the characteristics of patients who are of
higher risk, our study found that among the 2014-2017
Florida patient population, those who were younger,
male, and Caucasian were found to be more at risk of
being identified with an opioid abuse disorder. This is
an important finding because it supports other research
that as a person ages, they have a decreased risk of
opioid abuse.42,43 Furthermore, our findings support
studies that males are more likely to abuse opioids
compared to females.43,44 This is also consistent with
literature related to risk factors for opioid abuse among
veterans and younger adult males having a higher
prevalence of opioid abuse disorder.44 This study uses
data from multiple databases to provide valuable
insight into our understanding of potential predictors
for opioid abuse disorder. However, the data is
focused on Florida hospitals and the patient population
within Florida. Therefore, the results are not
generalizable to other states.
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